Join the club for FREE to access the whole archive and other member benefits.

James Bainbridge

Consultant Ophthalmic Surgeon-Scientist, Moorfields Eye Hospital, Chair of Retinal Studies, UCL

James Bainbridge is a surgeon-scientist. His  aim is to reduce the prevalence of blindness using translational research to develop effective new treatments for retinal vascular and neurodegenerative diseases. He collaborates widely in multidisciplinary research programmes to develop new molecular and cellular therapies. His own programme of research extends from the laboratory investigation of mechanisms of retinal disease in experimental models, through preclinical development of novel therapies, to clinical trials of new medical and surgical interventions. In 2007 he performed the World's first gene therapy for inherited blindness and in 2012 Europe's first stem cell transplantation for macular degeneration.


Areas of expertise:

 Retinal detachment

 Macular hole

 Epiretinal membrane

 Floaters

 Diabetic retinopathy

 Age-related macular degeneration (AMD)

 Retinal vein occlusion

 Vitreo-retinal conditions

 Cataract surgery

 Cataract surgery cost

Visit website: https://www.moorfields-private.co.uk/consultants/james-bainbridge

 james-bainbridge-97004810

See also: Health Organisation Moorfields Eye Hospital London - One of the world’s leading eye hospitals, providing expertise in clinical care, research and teaching and education

Details last updated 19-Feb-2020

James Bainbridge News

Brain can learn to see again using algae proteins

Brain can learn to see again using algae proteins

BBC - 24-May-2021

Optogenetics bring back vision partially with light sensing proteins - new hope for the blind

First gene therapy for a rare eye disease, now NHS-approved

First gene therapy for a rare eye disease, now NHS-approved

BBC - 17-Feb-2020

This life-changing new gene therapy will halt sight loss and improve vision